"Atlanta Center for Gastroenterology | Dr. David Rausher | Dr. Cliff Parrish | Decatur, GA 30033 Atlanta Center for Gastroenterology has been serving the residents of Dekalb County and the Atlanta community since 1982. Our Board Certified gastroenterologists are proud to provide the best quality healthcare in a compassionate and cost effective manner. Our patients are treated individually, as people, not just a number. They are seen in a comfortable, personalized environment and treated with respect and dignity. We are an independent private practice, not a conglomerate or multi-specialty clinic. Our intent is to personally serve the communities needs to the best of our abilities given each individual patient's unique situation."

During the past decade, Atlanta Center For Gastroenterology, P.C. conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 17 clinical trials were completed, i.e. on average, 65.4% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 11 clinical trials were completed. i.e. 84.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Atlanta Center For Gastroenterology, P.C." #1 sponsor was "Pfizer" with 6 trials, followed by "Shire" with 5 trials sponsored, "Celgene" with 3 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored and "Arena Pharmaceuticals" with 3 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Atlanta Center For Gastroenterology, P.C." #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator and "RTI Health Solutions" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Atlanta Center For Gastroenterology, P.C." are "Ulcerative Colitis" (15 trials), "Crohn's Disease" (7 trials), "Crohn Disease" (6 trials), "Colitis, Ulcerative" (2 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Atlanta Center For Gastroenterology, P.C." in a lesser frequency.

Most popular intervention types in "Atlanta Center For Gastroenterology, P.C." are "Drug" (33 trials), "Other" (8 trials), "Biological" (2 trials), "Procedure" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "Etrasimod" (4 trials), "Ontamalimab" (4 trials), "Ozanimod" (3 trials) and "Colonoscopy" (2 trials). Other intervention names were less common.

The vast majority of trials in "Atlanta Center For Gastroenterology, P.C." are 38 trials for "All" genders.

Currently, there are NaN active trials in "Atlanta Center For Gastroenterology, P.C.". undefined are not yet recruiting, 6 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Atlanta Center For Gastroenterology, P.C., undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Atlanta Center For Gastroenterology, P.C., 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".